Verici Logo

Shareholder Information

UK City Code on Takeovers and Mergers

The Company is subject to the provisions of the City Code on Takeovers and Mergers.

Other exchanges and trading platforms

Verici Dx has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms.

Shares in Issue

Number of AIM securities in issue: 141,747,816 shares are issued, called up and fully paid. The Company holds no shares in treasury.

This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Significant Shareholdings

Significant shareholdersNo. of ordinary shares % held
Christopher Mills*29,758,57220.99%
Icahn School of Medicine at Mount Sinai18,427,21613.00%
Renalytix AI plc9,831,6816.94%
Unicorn Asset Management Limited5,739,6604.05%
Amati Global Investors4,964,5333.50%
Octopus Investments4,324,2783.05%


*Christopher Mills is partner and Chief Investment Officer of Harwood Capital LLP. Harwood Capital LLP is Investment Manager to North Atlantic Smaller Companies Investment Trust plc and investment adviser to Oryx International Growth Fund Limited. Christopher’s shareholding is made up of 16,500,000 ordinary shares held by North Atlantic Smaller Companies Investment Trust PLC, 5,500,000 ordinary shares are held by Oryx International Growth Fund Limited and 7,758,572 ordinary shares are held by Harwood Capital LLP.

Director Shareholdings

On the date of Admission

  
DirectorNumber Ordinary Shares %
Julian Baines MBE1,351,7131%
James McCullough2,870,1102%
Dr Barbara Murphy150,8000.1%
Sir Ian Carruthers100,0000.1%

 

Shares not in public hands

Percentage of securities not in public hands: As at 11 January 2021 the percentage of AIM securities not in the public hands was 45.97%. The securities not in public hands include all substantial shareholders and  the directors and senior management who are classed as persons discharging managerial responsibilities.

Restrictions in transfer of AIM Securities

There are no restrictions on the transfer of the Company’s ordinary shares except for shareholders who received distribution in specie from Renalytix AI plc.

 

Last updated: 11 January 2021

© 2020 VericiDx
crossmenu